{"id":"W4210298192","doi":"10.1016/j.esmoop.2022.100403","title":"Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus","year":2022,"lang":"en","type":"article","venue":"ESMO Open","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; Janssen Pharmaceuticals; Chugai Pharmaceutical; AstraZeneca; Genentech; MorphoSys; PharmaMar; Daiichi Sankyo Europe; European Society for Medical Oncology; Deutsche Krebshilfe; Pfizer; José Carreras Leukämie-Stiftung; Shionogi; British Society for Haematology; National Institute for Health and Care Research; Bayer; Astellas Pharma; Celltrion; SkylineDx; Sanofi-Aventis Deutschland; BeiGene; Sanofi; TG Therapeutics; Medac; Ipsen; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; Meso Scale Diagnostics; Helsinn; Takeda Pharmaceutical Company; Novartis Pharma; AbbVie; AOP Orphan; Bundesministerium für Bildung und Forschung; EUSA Pharma; Merck KGaA; Incyte; Servier; Gilead Sciences; Celgene; Novartis; GlaxoSmithKline; Eli Lilly and Company; Bristol-Myers Squibb; Deutsche Forschungsgemeinschaft; Roche; Sierra Oncology; Galecto; Astellas Pharma US; Boehringer Ingelheim; Amgen","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Consensus conference; MEDLINE; Family medicine; 2019-20 coronavirus outbreak; Intensive care medicine; Political science; Internal medicine; Pathology; Disease; Law","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09079557,0.0009439173,0.001486748,0.003047213,0.004360786,0.005353872,0.003977233,0.01232834,0.005605056],"category_scores_gemma":[0.1024689,0.0007464748,0.002717224,0.001527522,0.002563212,0.005208162,0.01219853,0.01255309,0.002091667],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006134602,"about_ca_system_score_gemma":0.04535188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003105938,"about_ca_topic_score_gemma":0.005839888,"domain_scores_codex":[0.9432951,0.03209412,0.009476283,0.002367774,0.008967379,0.003799414],"domain_scores_gemma":[0.91135,0.02596599,0.004305072,0.00181266,0.04109683,0.01546946],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001695665,0.0003230375,0.00479443,0.004623916,0.0002609834,0.002763334,0.01129017,0.001301488,0.001714486,0.01566399,0.6836619,0.2734327],"study_design_scores_gemma":[0.0001223761,0.0001640587,0.003554903,0.024077,0.0002121711,0.002139469,0.01495691,0.001320941,0.000836885,0.03114392,0.9212872,0.0001842431],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.009692943,0.02469361,0.01520184,0.8973609,0.02968156,0.001460366,0.0006223468,0.0001512905,0.02113515],"genre_scores_gemma":[0.2349638,0.09469707,0.1539482,0.45023,0.02924606,0.004552327,0.004196483,0.0003934457,0.02777259],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.09079557,"threshold_uncertainty_score":0.4801786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1554210049298026,"score_gpt":0.4771415186154561,"score_spread":0.3217205136856536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}